Company Filing History:
2 out of 3 
1 out of 50 
1 out of 81 
Years Active: 2017-2020
Title: Dai Ogura: Innovator in Therapeutic Agents
Introduction
Dai Ogura is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of therapeutic agents, particularly in the treatment of choroidal neovascularization and various malignant tumors. With a total of 2 patents, Ogura's work is paving the way for innovative solutions in medical therapies.
Latest Patents
Ogura's latest patents include a choroidal neovascularization suppressor and a drusen formation suppressor. These inventions address the urgent need for therapeutic drugs that go beyond symptomatic therapy for choroidal neovascularization (CNV). The current market lacks effective therapeutic drugs for dry age-related macular degeneration (AMD), and Ogura's inventions aim to fill this gap. His work provides a prophylactic and therapeutic agent for CNV, utilizing compounds that suppress epithelial-mesenchymal transition in retinal pigment epithelial cells. Additionally, he has developed an antibody against transporter LAT1/CD98, which serves as a therapeutic agent for various malignant tumors, including solid tumors that are currently difficult to treat.
Career Highlights
Throughout his career, Dai Ogura has worked with notable organizations such as Link Genomics, Inc. and Kinki University. His experience in these institutions has allowed him to collaborate with other experts in the field and further his research in therapeutic innovations.
Collaborations
Ogura has collaborated with esteemed colleagues, including Shinichiro Niwa and Takashi Masuko. These partnerships have contributed to the advancement of his research and the development of his patents.
Conclusion
Dai Ogura's innovative work in therapeutic agents showcases his commitment to addressing critical medical needs. His patents represent significant advancements in the treatment of choroidal neovascularization and malignant tumors. Through his research and collaborations, Ogura continues to make a lasting impact in the field of medical innovation.